Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials We performed an open-label, randomized ...
Please provide your email address to receive an email when new articles are posted on . The regimen appeared associated with low rates of severe acute GVHD, chronic GVHD and nonrelapse mortality, as ...
All patients received a regimen of busulfan 1 mg/kg administered orally every 6 h for 4 successive days, followed by cyclophosphamide 60 mg/kg administered intravenously on each of 2 successive days ...
Busulfan influences engraftment and toxicities during hematopoietic stem cell transplantation (HSCT). We report our single-institution experience of targeted busulfan therapy for myeloablative, ...
Please provide your email address to receive an email when new articles are posted on . Patients with acute myelogenous leukemia in first remission treated with cyclophosphamide plus busulfan ...
Therapeutic drug monitoring (TDM) of Busulfan is essential for management of Bone Marrow Transplant (BMT) patients, by optimizing dose, supporting compliance, and minimizing toxicity. Busulfan is a ...
HOUSTON — Using a treosulfan-based myeloablative regimen in place of one based on busulfan may improve survival in vulnerable patients with acute myeloid leukemia (AML) and myelodysplastic syndrome ...
Details concerning the Busulfan (2mg) medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...
Therapeutic drug monitoring (TDM) of Busulfan is essential for management of Bone Marrow Transplant (BMT) patients, by optimizing dose, supporting compliance, and minimizing toxicity. Busulfan is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results